UB Paderborn / Katalog / Suche / in CDI

Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study

European journal of nutrition, 2018-09, Vol.57 (6), p.2133-2145

2018

Volltextzugriff (PDF)

Influence of HDL-cholesterol levels on HDL particles lipid composition in healthy individuals. an NMR-based lipidomic study

Atherosclerosis, 2016-09, Vol.252, p.e110-e110

2016

Volltextzugriff (PDF)

Investigation of the presence of ischemic heart disease by the 1H NMR-based lipidomics of red blood cell membranes

Atherosclerosis, 2015-07, Vol.241 (1), p.e124-e125

2015

Volltextzugriff (PDF)

Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine

Nephrology, dialysis, transplantation, 2011-10, Vol.26 (10), p.3219-3224

2011

Volltextzugriff (PDF)

Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients

Lipids, 2010-05, Vol.45 (5), p.445-450

2010

Volltextzugriff (PDF)

AB0342 Serum Transferrin Receptor Ratio to Serum Ferritin and Hepcidin Levels in the Differential Diagnosis of Anemia in Rheumatoid Arthritis Patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1008-1008

2015

Volltextzugriff (PDF)

Hypolipidemic treatment increases lipoprotein(a) levels in patients with mixed hyperlipidemia

Atherosclerosis, 2023-08, Vol.379, p.S46

2023

Volltextzugriff (PDF)

Effects of combinations of valsartan with amlodipine or hydrochlorothiazide on renal function and proteinuria in hypertensive patients with metabolic syndrome

Atherosclerosis, 2014-08, Vol.235 (2), p.e264-e264

2014

Volltextzugriff (PDF)

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

International journal of clinical practice (Esher), 2012-09, Vol.66 (9), p.843-853

2012

Volltextzugriff (PDF)

HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide

Atherosclerosis, 2020-12, Vol.315, p.e65-e65

2020

Volltextzugriff (PDF)

Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus

Atherosclerosis, 2019-08, Vol.287, p.e127-e128

2019

Volltextzugriff (PDF)

Investigation of the presence of ischemic heart disease by the1 H NMR-based lipidomics of red blood cell membranes

Atherosclerosis, 2015, Vol.241 (1), p.e124-e125

2015

Volltextzugriff (PDF)

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome: Effect of rosuvastatin monotherapy

International journal of clinical practice (Esher), 2012-09, Vol.66 (9), p.843-853

2012

Volltextzugriff (PDF)

Effect of rosuvastatin monotherapy or in combination with fenofibrate or [omega]-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

International journal of clinical practice (Esher), 2012-09, Vol.66 (9), p.843

2012

Volltextzugriff (PDF)

MS448 DIFFERENTIAL EFFECT OF SARTANS WITH VARIOUS PPARγ ACTIVATING CAPACITY COMBINED WITH ROSUVASTATIN ON GLUCOSE METABOLISM INDICES

Atherosclerosis. Supplements, 2010-06, Vol.11 (2), p.200-200

2010

Volltextzugriff (PDF)

P276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA

Atherosclerosis. Supplements, 2010-06, Vol.11 (2), p.75-75

2010

Volltextzugriff (PDF)

Abstract: P933 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL LEVELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME

Atherosclerosis. Supplements, 2009-06, Vol.10 (2), p.e1080-e1080

2009

Volltextzugriff (PDF)

PO23-726 EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH PRIMARY DYSLIPIDEMIAS

Atherosclerosis. Supplements, 2007-06, Vol.8 (1), p.193-193

2007

Volltextzugriff (PDF)

EFFECTS OF ORLISTAT AND FENOFIBRATE, ALONE OR IN COMBINATION, ON PLASMA APOLIPOPROTEIN C-II AND C-III LEVELS IN METABOLIC SYNDROME PATIENTS

Atherosclerosis. Supplements, 2008-05, Vol.9 (1), p.191-191

2008

Volltextzugriff (PDF)

Th-P16:404 Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemia

Atherosclerosis. Supplements, 2006, Vol.7 (3), p.582-582

2006

Volltextzugriff (PDF)

We-P11:104 LDL subfractions in patients with metabolic syndrome

Atherosclerosis. Supplements, 2006, Vol.7 (3), p.368-368

2006

Volltextzugriff (PDF)

On the estimation of the effect of weight change on a health outcome using observational data, by utilising the target trial emulation framework

International Journal of Obesity, 2023-12, Vol.47 (12), p.1309-1317

2023

Volltextzugriff (PDF)

Sharing of public health information in response to maritime outbreaks – report from an exercise conducted at a European level

European journal of public health, 2021-10, Vol.31 (Supplement_3)

2021

Volltextzugriff (PDF)

Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine

Neuroscience letters, 2009-07, Vol.25 (7), p.729-735

2009

Volltextzugriff (PDF)

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

Arthritis research & therapy, 2006-01, Vol.8 (3), p.R82-R82

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study

Influence of HDL-cholesterol levels on HDL particles lipid composition in healthy individuals. an NMR-based lipidomic study

Investigation of the presence of ischemic heart disease by the 1H NMR-based lipidomics of red blood cell membranes

Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine

Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients

AB0342 Serum Transferrin Receptor Ratio to Serum Ferritin and Hepcidin Levels in the Differential Diagnosis of Anemia in Rheumatoid Arthritis Patients

Hypolipidemic treatment increases lipoprotein(a) levels in patients with mixed hyperlipidemia

Effects of combinations of valsartan with amlodipine or hydrochlorothiazide on renal function and proteinuria in hypertensive patients with metabolic syndrome

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide

Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus

Investigation of the presence of ischemic heart disease by the1 H NMR-based lipidomics of red blood cell membranes

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome: Effect of rosuvastatin monotherapy

Effect of rosuvastatin monotherapy or in combination with fenofibrate or [omega]-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

MS448 DIFFERENTIAL EFFECT OF SARTANS WITH VARIOUS PPARγ ACTIVATING CAPACITY COMBINED WITH ROSUVASTATIN ON GLUCOSE METABOLISM INDICES

P276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA

Abstract: P933 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL LEVELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME

PO23-726 EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH PRIMARY DYSLIPIDEMIAS

EFFECTS OF ORLISTAT AND FENOFIBRATE, ALONE OR IN COMBINATION, ON PLASMA APOLIPOPROTEIN C-II AND C-III LEVELS IN METABOLIC SYNDROME PATIENTS

Th-P16:404 Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemia

We-P11:104 LDL subfractions in patients with metabolic syndrome

On the estimation of the effect of weight change on a health outcome using observational data, by utilising the target trial emulation framework

Sharing of public health information in response to maritime outbreaks – report from an exercise conducted at a European level

Effects of nutritional intervention on body weight and body composition of obese psychiatric patients taking olanzapine

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

Suchergebnisse filtern